IINN Inspira Technologies Oxy B.H.N. Ltd. logo

IINN Inspira Technologies Oxy B.H.N. Ltd.

Healthcare
$0.30-22.56%ClosedMarket Cap: $7.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

3.49

P/S

25.26

EV/EBITDA

-0.65

DCF Value

$0.11

FCF Yield

0.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.7%

Operating Margin

2503.5%

Net Margin

-2213.8%

ROE

-278.1%

ROA

-119.8%

ROIC

258.1%

Financials

View All
PeriodRevenueNet IncomeEPS
FY null$289.0K$-13.2M$
Q2 null$144.5K$-3.2M$
Q1 null$144.5K$-3.2M$
FY null$0.00$-11.1K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Rozanovich Yoavofficer
SellThu Apr 23
shabtay abrahamofficer: COO and VP of R&D
SellTue Mar 24
shabtay abrahamofficer: COO and VP of R&D
SellTue Mar 24
Yechezkely Hayon Daniellaofficer: Chief Technology Officer
SellThu Mar 19
Tehila Yafitofficer: Chief Financial Officer
SellThu Mar 19

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

IL

Exchange

Beta

2.16

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Peers